Immunotitration of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in various physiological states.

Abstract
The immunotitration of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase [mevalonate:NADP+ oxidoreductase (CoA-acylating), EC 1.1.1.34], the major regulatory enzyme in cholesterol biosynthesis, by HMG-CoA reductase antiserum is described. This technique provides the advantage that relative changes can rapidly be measured in both enzyme concentration and enzyme activity in different physiological states using enzyme samples all the way from crude liver microsomes to purified enzyme. Regarding the diurnal rhythm of HMG-CoA reductase, the major difference noted between rats killed near the middle of the dark period (D 4.5) compared to animals killed near the middle of the light period (L 4.5) was in the concentration of HMG-CoA reductase present, rather than in the activity of the enzyme, with substantially more enzyme found near mid-dark. Cholestyramine treatment resulted in both an increased concentration of HMG-CoA reductase and a catalytically more active enzyme. Cholesterol feeding resulted in both a decreased concentration of HMG-CoA reductase and a catalytically less active enzyme.

This publication has 36 references indexed in Scilit: